Literature DB >> 9166820

Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements.

D Elstein1, I Hadas-Halpern, Y Azuri, A Abrahamov, Y Bar-Ziv, A Zimran.   

Abstract

A comparison was made between volume measurements of spleen and liver by ultrasonography and by computed tomography, the two most common modes of assessment of organ size in patients with Gaucher disease, who require frequent follow-up measurements. The two measurements showed a high degree of correlation within a broad range for both spleen and liver volumes. An algorithm for conversion of one measurement to the other was derived for both spleen and liver.

Entities:  

Mesh：

Year:  1997        PMID： 9166820     DOI： 10.7863/jum.1997.16.3.209

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN： 0278-4297            Impact factor:   2.153


  16 in total

1.  Automated segmentation and quantification of liver and spleen from CT images using normalized probabilistic atlases and enhancement estimation.

Authors:  Marius George Linguraru; Jesse K Sandberg; Zhixi Li; Furhawn Shah; Ronald M Summers
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

2.  Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.

Authors:  Pramod K Mistry; Neal J Weinreb; Paige Kaplan; J Alexander Cole; Andrea R Gwosdow; Thomas Hangartner
Journal:  Blood Cells Mol Dis       Date:  2010-11-26       Impact factor: 3.039

3.  Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.

Authors:  Azza Abdel Gawad Tantawy; Eman Mounir Sherif; Amira Abdel Moneam Adly; Sahar Hassanine; Amina Hafez Awad
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

4.  Portal hypertension and hypersplenism in extrahepatic portal venous obstruction: Are they related?

Authors:  Ragini Kilambi; Anand Narayan Singh; Kumble Seetharama Madhusudhan; Sujoy Pal; Renu Saxena; Nihar Ranjan Dash; Peush Sahni
Journal:  Indian J Gastroenterol       Date:  2018-06-23

5.  Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

Authors:  Gregory A Grabowski; Katherine Kacena; J Alexander Cole; Carla E M Hollak; Lin Zhang; John Yee; Pramod K Mistry; Ari Zimran; Joel Charrow; Stephan vom Dahl
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

6.  Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening.

Authors:  Amy C Yang; Louise Bier; Jessica R Overbey; Jessica Cohen-Pfeffer; Khyati Desai; Robert J Desnick; Manisha Balwani
Journal:  Genet Med       Date:  2016-10-13       Impact factor: 8.822

7.  Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation.

Authors:  Margaret M McGovern; Melissa P Wasserstein; Bruno Bembi; Roberto Giugliani; K Eugen Mengel; Marie T Vanier; Qi Zhang; M Judith Peterschmitt
Journal:  Orphanet J Rare Dis       Date:  2021-05-10       Impact factor: 4.123

8.  Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment.

Authors:  Neal J Weinreb; Jack Goldblatt; Jacobo Villalobos; Joel Charrow; J Alexander Cole; Marcelo Kerstenetzky; Stephan vom Dahl; Carla Hollak
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

9.  Assessing hepatomegaly: automated volumetric analysis of the liver.

Authors:  Marius George Linguraru; Jesse K Sandberg; Elizabeth C Jones; Nicholas Petrick; Ronald M Summers
Journal:  Acad Radiol       Date:  2012-02-22       Impact factor: 3.173

10.  Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experience.

Authors:  Irina Tukan; Irith Hadas-Halpern; Gheona Altarescu; Ayala Abrahamov; Deborah Elstein; Ari Zimran
Journal:  Adv Hematol       Date:  2013-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.